ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of Section 122(3) of The Companies Act and Section 3.83(b) of The JSE Listings Requirements

2018-07-12 11:00:00

APN 201807120029A
Notification in terms of Section 122(3) of The Companies Act and Section 3.83(b) of The JSE Listings Requirements

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
('Aspen' or 'the Company')



NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND
SECTION 3.83(b) OF THE JSE LISTINGS REQUIREMENTS


In accordance with section 122(3)(b) of the Companies Act, No. 71 of 2008 (“the Act”) and section
3.83(b) of the JSE Listings Requirements, holders of ordinary shares in the Company are advised
that Harding Loevner LP have formally notified the Company that they have acquired a beneficial
interest in the securities of the Company now amounting to 5.01% of the ordinary share capital of
the Company, effective 5 July 2018.

Aspen will file the required notice with the Takeover Regulation Panel as required in terms of
section 122(3)(a) of the Act.


Durban
12 July 2018

Sponsor
Investec Bank Limited

Date: 12/07/2018 11:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.